drugset / Trial / NCT01122251
Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential Hypertension
RandomizedFactorialDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of fixed combination of lercanidipine (10 mg or 20 mg) and valsartan (80 mg or 160 mg), lercanidipine and valsartan alone in reducing blood pressure. The study will investigate the dose response relationship for the combinations and monotherapies.
Timeline
- Start
- 2009-12
- Primary completion
- 2010-05
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lercanidipine | Small molecule | 10 mg | — |
| Subject | Lercanidipine | Small molecule | 20 mg | — |
| Subject | Valsartan | Small molecule | 80 mg | — |
| Subject | Valsartan | Small molecule | 160 mg | — |